Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$4.81 - $11.92 $73,136 - $181,243
-15,205 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$11.34 - $21.37 $51,030 - $96,165
-4,500 Reduced 22.84%
15,205 $183,000
Q2 2021

Aug 16, 2021

SELL
$19.4 - $28.71 $284,016 - $420,314
-14,640 Reduced 42.63%
19,705 $417,000
Q4 2020

Feb 16, 2021

SELL
$24.2 - $35.76 $606,936 - $896,860
-25,080 Reduced 42.2%
34,345 $893,000
Q3 2020

Nov 13, 2020

SELL
$31.18 - $52.71 $41,344 - $69,893
-1,326 Reduced 2.18%
59,425 $2.21 Million
Q2 2020

Aug 14, 2020

BUY
$30.04 - $51.31 $461,023 - $787,454
15,347 Added 33.8%
60,751 $3.12 Million
Q1 2020

May 14, 2020

BUY
$27.44 - $73.84 $150,426 - $404,790
5,482 Added 13.73%
45,404 $1.43 Million
Q4 2019

Feb 13, 2020

BUY
$35.4 - $59.82 $1.41 Million - $2.39 Million
39,922 New
39,922 $2.38 Million
Q2 2019

Aug 08, 2019

SELL
$40.1 - $52.33 $1.25 Million - $1.63 Million
-31,078 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$40.11 - $53.57 $496,922 - $663,678
-12,389 Reduced 28.5%
31,078 $1.25 Million
Q4 2018

Feb 14, 2019

SELL
$36.99 - $59.11 $874,369 - $1.4 Million
-23,638 Reduced 35.23%
43,467 $1.97 Million
Q2 2018

Aug 13, 2018

BUY
$36.2 - $76.4 $1.62 Million - $3.41 Million
44,654 Added 198.9%
67,105 $2.63 Million
Q1 2018

May 14, 2018

BUY
$65.94 - $80.76 $1.48 Million - $1.81 Million
22,451 New
22,451 $1.62 Million

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $112M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.